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Familial spastic paraplegia (FSP) is a clinically and genetically heterogeneous group of neurodegenerative disorders mainly characterised by progressive spasticity of the lower limbs (spastic gait, hyperreflexia, clonus, and Babinski sign).' The basic pathological features of FSP are degeneration of the crossed pyramidal tracts and thinning of the dorsal columns. FSP is commonly divided into two forms2 depending on whether spasticity occurs in isolation ("pure" FSP, MIM 182600)' or associated with a wide range of additional symptoms ("complicated" FSP), such as mental retardation (MIM 270850,270950,182690), ichthyosis, optic atrophy (MIM 182830), dementia (MIM 182830), epilepsy, ataxia, deafness (MIM 312910, 182690) , and peripheral neuropathies (MIM 182800). FSP can be inherited in an autosomal dominant (AD-FSP), autosomal recessive (AR-FSP), or X linked (X-FSP) manner. Within each inheritance pattern, FSP exhibits both clinical variability and genetic heterogeneity. Genetic heterogeneity was first described for two different forms of X linked FSP; in a family manifesting X-FSP associated with mental retardation and optic atrophy, the disease gene was mapped to Xq28 markers (locus SPG1),4 while linkage to the Xq21-22 region (locus SPG2) was reported in a kindred with pure X-FSP.' Pure AD-FSP and AR-FSP were also shown to be genetically heterogeneous.6 A locus for AR-FSP has been mapped to chromosome 8 (SPG5)7 and three loci responsible for pure AD-FSP have been localised on fig 1) were examined by the authors (OH, MM, JD, and JP) and seven met the disease criteria defined as follows: (1) subjects with progressive spastic paraplegia showing pyramidal signs in the lower limbs (spasticity, increased reflexes, and Babinski sign) and an asymptomatic patient with bilateral extensor plantar reflexes were considered to be affected; (2) the asymptomatic family members with normal neurological examination were considered unaffected. Disability was assessed on a three point scale as previously described": 1 Lod scores were calculated at different recombination fractions, assuming complete penetrance or using the liability classes (LC) described in the Methods.
(revised), he obtained an index score of 84 for verbal memory, 87 for visual memory, 93 for delayed recall, and 101 for attention. He was at the 50th centile in the copy subtest and only the 15th centile in the recall subtest of the Rey figure.
HAPLOTYPE AND LINKAGE ANALYSIS Four microsatellite markers from the three different AD-FSP loci were initially chosen from a published set2' and tested for linkage to FSP in family CM: D14S1055, D14S255, D14S269, and D14S1018 for locus SPG3; D2S352, D2S367, D2S2347, and D2S2283 for locus SPG4; and D15S1035, D15S128, D15S156, and D15S122 for locus SPG6. The chromosome 14q and 15q candidate regions were entirely excluded (Z <-2) by two point analyses in family CM, whereas maximum lod scores of 3.49 and 3.26 at 0=0 were obtained with locus D2S2325, assuming complete penetrance and using liability classes, respectively. In a previous study of subclinical cognitive impairment in FSP patients, all the people affected with complicated AD-FSP had cognitive deficits on neuropsychological tests,27 such as lack of concentration, slowness to respond to the examiner, poor capacity for retaining new information, and temporospatial disorientation. On the other hand, pedigrees displaying AD-or AR-FSP complicated by dementia or clinically evident cognitive impairment are rare. 22 23 [28] [29] [30] In an Irish kindred reported previously,22 one affected member died of dementia and six had cognitive deficits with predominant visuospatial impairment in neuropsychological studies. Similarly, in family CM, one patient had severe dementia while three had cognitive impairment, but the neuropsychological deficit seems rather different from that described in the Irish kindred. Furthermore, cognitive impairment cosegregates with epilepsy in family CM. To our knowledge, the association ofAD-FSP, dementia, and epilepsy has not been described previously.
In the present study, we report the first localisation of a gene responsible for a form of AD-FSP complicated by epilepsy and cognitive impairment. Our data clearly establish significant linkage between the disease causing gene in family CM and the SPG4 locus known to be associated with pure AD-FSP." At this stage of the study, three hypotheses might account for this result: (1) 
